Schedule 13G ownership disclosure

Boston Therapeutics, Inc.

Security class unavailable · CUSIP: 101150100

Event date: 2015-09-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-056259
Form type
SC 13G/A
Filer
NANOMIX Corp
CIK
CIK 1473579
Filed
Sep 24, 2015
Reporting period
Sep 23, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub